Newly Identified Genetic Eye Disease Impairs Night, Peripheral Vision; Linked to EFEMP1 Variant
Scientists have identified a rare genetic condition that slowly impairs night vision and peripheral sight, often remaining asymptomatic for most of a person’s life.
Researchers linked the disorder to a specific variant in the EFEMP1 gene, according to a study published in JAMA Ophthalmology on Sunday.
The condition, which researchers are calling EFEMP1-associated late-onset retinal degeneration (L-ORD), stems from a p.Arg140Trp genetic variant. This mutation causes an accumulation of thick material between eye cells, ScienceDaily reported. While the same gene is known to cause a different disorder affecting central vision, this newly identified variant specifically targets the peripheral retina.
An international team, including researchers from the Scheie Eye Institute at the University of Pennsylvania, began tracing the disorder to a family documented in 1998. By comparing this case with European families, the team established that the condition develops in the outer regions of the retina. Patients often maintain normal eyesight for decades before experiencing narrowing side vision or difficulty seeing in dim light, scitechdaily.com reported.
Detecting the condition remains a clinical challenge because the eye’s structure may appear normal during early stages. However, researchers identified a functional marker: rod cells in the retina take an unusually long time to recover when a person moves from bright light into darkness.
“We can detect a major abnormality in the way rod photoreceptors recover in darkness with retinas that still look structurally intact,” said Artur V. Cideciyan, an ophthalmology researcher and co-director of the Center for Hereditary Retinal Degenerations. “This gives us a functional marker of disease at a stage when photoreceptor cells have not yet been lost.”
The study involved collaboration across several institutions, including the University of Edinburgh, the University of Basel, Charles University, and the University of Bonn.
Scientists hope that investigating this rare disorder will provide broader insights into age-related retinal conditions.
“Lessons learned from these infrequent, late-onset genetic eye diseases offer glimpses at possible mechanisms of disease for much more frequent retinal problems,” said Tomas S. Aleman, a professor of ophthalmology and co-director of the Center for Hereditary Retinal Degenerations.
Researchers do not yet know how many people carry the p.Arg140Trp variant or the full prevalence of the disease. Larger studies are required to determine how widely this genetic change occurs in the general population.